Chemicalinfo Chemlink Pharm-Chem Net

Gilead patent case to help Indian firms25 Jan 2008, 0027 hrs IST,Rupali Mukherjee,TNNNEW DELHI: The US Patent & Trademark Office's rejection of four patents held by Gilead Sciences on a key HIV drug Tenofovir, paves the way for a more affordable ...

En Mйxico se usan anabуlicos en forma legal en el 70% del ganado En los ъltimos aсos se ha satanizado el uso de anabуlicos para engordar el ganado por las intoxicaciones generadas por el uso del Clenbuterol (anabуlico que se utiliza en forma ile...

Synta Pharmaceuticals Initiates Second Phase 1 Clinical Trial of STA-9090, A Novel Hsp90 Inhibitor

Cancer drug puts licence, patent rules to test THE drugs manufacturing industry is on a state of alert following two landmark developments over a cancer treatment medicine.   ...

Scrip Yearbook 2008 Charts the Progress of the Pharmaceutical Industry as Reported in Scrip World Pharmaceutical News over the 12 Months up to the End of November 2007  DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researcha...

AZT, 3TC and efavirenz: a tolerable first-line regimen for South African men Derek Thaczuk, Monday, January 07, 2008 The safety and tolerability of a first-line regimen of AZT, 3TC and efavirenz has been assessed in ...

India can dominate global pharma landscapeBy staff reporter07/01/2008 - Although India 'has carved out a significant portion of the world pharma pie', an enormous change in mindset is needed if the country is to become a global pharmaceutical hub, ac...

WuXi PharmaTech makes its first acquisitionBy Kirsty Barnes07/01/2008 - WuXi PharmaTech, China's contract research titan, has orchestrated its first acquisition, gaining biologics capabilities and a base in the US. The firm has agreed to pay $151m fo...